Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Kaiser Daily Global Health Policy ReportDisease Outbreaks Search Results « » The Henry J. Kaiser Family Foundation

Disease Outbreaks

  • your selections
Clear Search

Filter Results



  • results
Despite Rising Measles Vaccination Rates Worldwide, Eradication Goal Remains Elusive

Nature: Measles by the numbers: A race to eradication “…Measles debate has reached fever pitch in the United States after an outbreak that began in December at Disneyland in southern California. … However, the bigger problem lies elsewhere. The United States was declared free of measles in 2000, and all…

Madagascar Plague Outbreak Slows; 71 Dead From Disease, WHO Says

Reuters: Spread of plague slows in Madagascar, death toll at 71: WHO “An outbreak of plague in Madagascar has slowed but 71 people among the 263 known to have caught the disease since last September have died, the World Health Organization (WHO) said on Wednesday…” (Miles, 2/11).

Vaccines Represent ‘Vital Early Weapon’ For Next Ebola Outbreak

The Lancet Global Health: Ebola vaccines: an uncertain future? Zoë Mullan, editor of The Lancet Global Health “…The rapid roll-out of these [Ebola vaccine] trials has been tremendously impressive. … Vaccines are not a magic bullet. Nothing can replace the basic tenets of public health epidemiology and community mobilization. But…

Blog Post Summarizes Obama’s Remarks On U.S. Ebola Response

U.S. Department of State’s “DipNote”: Progress in the Fight Against Ebola The blog post summarizes President Barack Obama’s remarks regarding the U.S. Ebola response in West Africa made on Wednesday during a White House event (2/11).

Ebola Treatment Clinical Trials Face Hurdles As Number Of Patients Shrinks

ScienceInsider: ‘Positive’ results for Ebola drug upsets plans for trials “…The Guinean government has already announced it wants to make [the experimental Ebola drug] favipiravir available to more people, and if the results hold up to greater scrutiny, they could force a change in the design of other clinical trials…